The metabolic cost of lowering blood pressure with hydrochlorothiazide

BACKGROUND: The landmark Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) placed a new spotlight on thiazide diuretics as the first-line therapy for hypertension. This is concerning as thiazide-diuretics may contribute to comorbidities associated with the current...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Price, Angela L, Lingvay, Ildiko, Szczepaniak, Edward W, Wiebel, Jaime, Victor, Ronald G, Szczepaniak, Lidia S
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3711837/
https://ncbi.nlm.nih.gov/pubmed/23837919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-5-35
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky